ArticleThe Journal of international medical research2026
Persistent CD8+ T-cell activation (HLA-DR/CD38) as an immunological marker in antiretroviral-treated human immunodeficiency virus-1 patients: A cross-sectional study.
Filiz Kibar et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.